Trupanion Inc. (TRUP)
NASDAQ: TRUPHealth CareMedical SpecialitiesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
TRUP stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.54B
- P/E (TTM)
- 58.30
- Forward P/E
- 8.14
- EPS (TTM)
- $0.61
- Dividend yield
- None
- 52-week range
- 21.16 – 38.87
- Day range
- 35.25 – 36.99
- Volume / Avg
- 495.39K / 443.82K
- Beta
- —
- Shares outstanding
- 43.26M
52-week range
TRUP stock today
Shares of Trupanion (TRUP) finished lower on Nov 20 at $35.56, a drop of 0.86% or $0.31 per share, versus the S&P 500's 3.70% decline. Shares are 8.5% below their 52-week high of $38.87, set on Dec 22, 2025 and 68.1% above the 52-week low of $21.16, near the top of the past year's range. TRUP is down 4.8% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 0.9%.
At 58.3x trailing earnings, Trupanion trades above the peer-group median of 30.9x. Its forward P/E of 8.1x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About Trupanion
Company profileTrupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on subscription basis in the United States, Canada, and Continental Europe. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
- Sector
- Health Care
- Industry
- Medical Specialities
- CEO
- Ms. Margaret Rosemary Maria Tooth
- Headquarters
- Seattle, WA
- Employees
- 1,121
- Website
- trupanion.com
Financial highlights
Full financialsIn fiscal 2025, Trupanion generated $1.44 billion in revenue, up 11.9% from fiscal 2024, its 13th consecutive year of revenue growth. Net income was $19.4 million, for a net margin of 1.4% versus a median of -4.0% in the prior 5 years. Gross margin was 16.1% (up from 13.9%) and operating margin 1.0%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $1.44B | $1.29B | $1.11B | $905.18M | $698.99M |
| Growth | +11.95% | +15.97% | +22.47% | +29.50% | +39.23% |
| Net income | $19.43M | $-9.63M | $-44.69M | $-44.67M | $-35.53M |
| EPS (diluted) | $0.45 | $-0.23 | $-1.08 | $-1.10 | $-0.89 |
Analyst forecast
ForecastConsensus (6 analysts)
buy
Avg. price target
$36.75+3.35%
- Strong buy 0
- Buy 2
- Hold 4
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 5, 2026
- EPS actual vs est.
- $0.21 vs $0.16
- Surprise
- +31.25%
TRUP news
All TRUP news- Trupanion Recognized Among Canada’s Best for Customer Service by NewsweekGlobeNewswire
- Trupanion expects $179M-$182M of adjusted operating income in 2026 while advancing a new digital product launch next summerSeeking Alpha
- Zacks Industry Outlook Highlights Aflac, Unum, Globe, Trupanion and EmployersNasdaqAFL, UNM, EIG, TRUP
- Trupanion Q3 Earnings Call HighlightsNasdaq
- Trupanion, Inc. Reports Third Quarter 2026 ResultsNasdaq
- Trupanion GAAP EPS of $0.21 beats by $0.06, revenue of $405.6M beats by $3.07MSeeking Alpha
- 5 Accident & Health Insurers to Watch Despite Cost PressureNasdaqAFL, UNM, EIG, TRUP
- Aflac (AFL) Surpasses Q3 Earnings and Revenue EstimatesNasdaqAFL, TRUP
Trupanion peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PSNLPersonalis Inc. | 14.27 | -3.06% | $1.55B | vs TRUP |
| LMRILumexa Imaging Holdings Inc. | 14.26 | +1.42% | $1.37B | vs TRUP |
| ALHCAlignment Healthcare Inc. | 6.37 | -2.00% | $1.33B | vs TRUP |
| FTREFortrea Holdings Inc. | 18.55 | -7.94% | $1.79B | vs TRUP |
| CLOVClover Health Investments Corp. Class A | 3.73 | -1.06% | $2.00B | vs TRUP |
| VCYTVeracyte Inc. | 25.13 | +0.36% | $2.03B | vs TRUP |
| FRNMFreenome Inc. | 9.36 | -5.69% | $1.04B | vs TRUP |
| CSTLCastle Biosciences Inc. | 32.86 | -1.63% | $1.01B | vs TRUP |
Indexes, lists and sector
Trupanion stock FAQ
What is Trupanion's stock price today?
TRUP last traded at $35.56 as of Nov 20, 4:00 PM EST, down 0.86% on the day. Prices are delayed at least 15 minutes.
What is TRUP's P/E ratio?
TRUP trades at a trailing P/E ratio of 58.30 and a forward P/E of 8.14, compared with a median of 30.9 for its closest peers.
Who is Trupanion's CEO?
Ms. Margaret Rosemary Maria Tooth is the chief executive officer of Trupanion Inc., which has about 1,121 employees.
What is the TRUP 52-week high?
The 52-week high for TRUP is $38.87 and the 52-week low is $21.16. The stock is currently 8.5% below its high.